Updating what we know about depression in adolescents

Journal of Psychosocial Nursing and Mental Health Services

Volumn 36, Issue 9, 1998, Pages 12-19

  Mohr, Wanda K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; CHILD; CHILD PSYCHOLOGY; DEPRESSION; FEMALE; HUMAN; MALE; REVIEW;

ADOLESCENT; ADOLESCENT PSYCHOLOGY; ANTIDEPRESSIVE AGENTS; CHILD; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE;

EID: 0032158981     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Abramowicz, M. (1990). Sudden death in children treated with a tricyclic antidepressant. The Medical Letter on Drugs and Therapeutics, 32, 53.
2. Ambrosini, P.J., Bianchi, M.D., Rabinovich, H., & Elia, J. (1993). Antidepressant treatments in children and adolescents. Part I: Affective disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1-6.
3. American Nurses Association. (1994). Standards of psychiatric and mental health nursing practice. Washington, DC: Author.
4. Boulos, C., Kutcher, S., Marton, P., Simeon, J., Ferguson, B., & Roberts, N. (1991). Response to desipramine treatment in adolescent major depression. Psychopharmacalogy Bulletin, 27(1), 59-63.
5. Brage, D.G. (1995). Adolescent depression: A review of the literature. Archives of Psychiatric Nursing, 9, 45-55.
6. Branchey, L., Branchey, M. Shaw, S., & Lieber, C.S. (1984). Depression, suicide and aggression and their relationship to plasma amino acids. Psychiatric Research, 12, 219-226.
7. Byalick, M. (1998). More pupils taking prescribed drugs to relieve distress. The New York Times (May 3) Section 14 LI, 10.
8. Campbell, M., & Cueva, J.E. (1995). Psychopharmacology in child and adolescent psychiatry: A review of the past seven years. Part I. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1262-1272.
9. Cantwcll, D.P., & Baker, L. (1991). Manifestations of depressive affect in adolescence. Journal of Youth and Adolescence, 20, 121-133.
10. Coccaro, E.F., Siever, L.J., & Klar, H.M. (1989). Serotonergic studies in patients with affective and personality disorders. Archives of General Psychiatry, 46, 587-599.
11. Cooper, J.R., Bloom, F.E., & Roth, R.H. (1996). The biochemical basis of neuropharmacology, 7th ed. New York: Oxford University Press.
12. Delgado, P.L., Price, L.H., Heninger, G.R., & Charney, D.S. (1992). Neurochemistry. In E.S. Paykel (Ed.), Handbook of affective disorders (pp. 219-253). Edinburg, United Kingdom: Churchill Livingstone.
13. Gelder, M., Gath, D., Mayou, R., & Cowen, P. (1996). Oxford textbook of psychiatry, 3rd ed., Oxford, United Kingdom: Oxford University Press.
14. Geller, B., Cooper, T.B., Graham, D.L., Marsteller, F.A., & Bryant, D.M. (1990). Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma" design. Psychopharmacology Bulletin, 26(1), 85-90.
15. Glod, C.A. (1998). Contemporary psychiatric-mental health nursing: The brain-behavior connection. Philadelphia:F.A. Davis.
16. Green, W.H. (1995). Child and adolescent clinical psychopharmacology. Philadelphia:Williams and Wilkins.
17. Killeen, M.R., & Bongarten, C.F. (1996). Caring for depressed children and adolescents. In A.B. McBride, & J.K. Austin (Eds.), Psychiatric-Mental health nursing (pp. 189-234). Philadelphia:W.B. Saunders.
18. Kovacs, M. (1996). Presentation and course of major depressive disorder during childhood and later years of the lifespan. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 705-715.
19. Kramer, A.D., & Feiguine, R.J. (1981). Clinical effects of amitriptyline in adolescent depression. Journal of the American Academy of Child Psychiatry; 20, 636-644.
20. Laraia, M.T. (1996). Current approaches to the psychopharmacologic treatment of depression in children and adolescents. Journal of Child and Adolescent Psychiatric Nursing, 9(1), 15-26.
21. Nurnberger, J.I., & Gershon, E.S. (1992). Genetics. In E.S. Paykel (Ed.), Handbook of affective disorders (pp. 132-148). Edinburgh, United Kingdom:Churchill Livingstone.
22. Perry, BD, Pollard, R.A., Blakley, T.L., Baker, W.L., & Vigilante, D. (1995). Childhood trauma, the neurobiology of adaptation, and "Use-dependent" development of the brain: How "states" become "traits." Infant Mental Health Journal, 16, 271-289.
23. Riddle, M.A., Geller, B., & Ryan, N. (1993). Another sudden death in a child treated with desipramine. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 792-797.
24. Riddle, M.A., King, R.A., Hardini M.T., Scahill, L. Ort, S.I., Chappell, P., Rasmusson, M.D., & Leckman, J.F. (1991) Behavioral side effects of fluoxetine. Journal of Child and Adolescent Psychopharmacology, 1, 193-198.
25. Rush, A.J., Kain, J.W., & Rease, J. (1991). Neurological bases for psychiatric disorders. In R.N. Rosenberg (Ed.), Comprehensive neurology (pp. 555-603). New York: Raven.
26. Ryan, N.D. (1990). Pharmacotherapy of adolescent major depression: Beyond TCAs. Psychopharmacology Bulletin, 20(1), 75-79.
27. Ryan, N.D., Meyer, V., Dachille, S., Mazzie, D., & Puig-Antich, J. (1988a). Lithium antidepressant augmentation in TCA-refractory depression in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 371-376.
28. Ryan, N.D., Puig-Antich, J., Cooper, T., Rabinovich, H., Ambrosini, P., Davies, M., King, J., Torres, D., & Fried, J. (1986). Imipramine in adolescent major depression: Plasma level and clinical response. Acta Psychiatrica Scandinavia, 73, 275-288.
29. Ryan, N.D., Puig-Antich, J., Cooper, T., Rabinovich, H., Ambrosini, P., Davies, M., King, J., Torres, D., & Fried, J. (1994). Response to desipramine treatment in adolescent depression: A filled dose, placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 686-694.
30. Ryan, N.D., Puig-Antich, J., Rabinovich, H., Fried, J., Ambrosini, P., Meyer, V., Torres, D., Dachille, S., & Mazzie, D. (1988b). MAOIs in adolescent major depression unresponsive to tricyclic antidepressants. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 755-758.
31. Sadler, L.S. (1991). Depression in adolescents: Context, manifestations, and clinical management. Nursing Clinics of North America, 26, 559-572.
32. Sadler, L.S. (1993). Adolescent depression. Journal of School Nursing, 9(1), 12-19.
33. Schwartz, E.D., & Perry, B.D. (1994). The post-traumatic response in children and adolescents. Psychiatric Clinics of North America, 17, 311-326.
34. Simeon, J.G., Dinicola, V.F., Ferguson, H.B., & Copping, W. (1990). Adolescent depression: A placebo-controlled fluoxetine treatment study and follow-up. Progressive Neuro-Psychopharmacological and Biological Psychiatry, 14, 791-795.
35. Strober, M., Freeman, R., & Rigali, J. (1990). The pharmacotherapy of depressive illness in adolescence: An open label trial of imipramine. Psychopharmacology Bulletin, 26(1), 80-84.
36. Van Woerskoem, T.C., Teelken, A.W., & Minderhoud, J.M. (1977). Differences in neurotransmitter metabolism in frontotemporal lobe contusion and diffuse cerebral contusion. Lancet, I, 812-813.